Picture of Progyny logo

PGNY — Progyny News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Progyny Inc reports results for the quarter - Earnings Summary

* Progyny Inc  PGNY.OQ  reported quarterly adjusted earnings
of 11
cents​​ per share for the quarter , lower than the same quarter
last year, when the company reported EPS of 16 cents.  The mean
expectation of eleven analysts for the quarter was for earnings
of 13 cents per share. Wall Street expected results to range
from 12 cents to 15 cents per share.
    * Revenue rose 2% to $286.63 million from a year ago;
analysts
expected $296.88 million. 
    * Progyny Inc's reported EPS for the quarter was 11 cents​.
    * The company reported quarterly net income of $10.42
million.
    * Progyny Inc shares had risen by 1.8% this quarter and
lost 54.1%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the managed
healthcare
peer group is also "buy"

Wall Street's median 12-month price target for Progyny Inc is
$23.00 
This summary was machine generated from LSEG data November 12 at
11:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.13           0.11           Missed
 Jun. 30 2024      0.17           0.17           Met
 Mar. 31 2024      0.13           0.17           Beat
 Dec. 31 2023      0.11           0.13           Beat

Recent news on Progyny

See all news